Last reviewed · How we verify
APVO436
At a glance
| Generic name | APVO436 |
|---|---|
| Sponsor | Aptevo Research and Development LLC |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML (PHASE1)
- Study of APVO436 in Patients With AML or MDS (PHASE1)
- Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |